Czym jest lek biopodobny?
Ten zestaw narzędzi dla pacjentów został opracowany przez firmę ecancer we współpracy z Europejską Koalicją Pacjentów Onkologicznych, aby zapewnić pacjentom wszechstronne zasoby dotyczące leków biopodobnych. Sześć modułów dostarcza kluczowych informacji i praktycznych porad, które pomogą Ci w podejmowaniu świadomych decyzji dotyczących leczenia.
Ten zasób e-learningowy jest wspierany przez nieograniczoną dotację edukacyjną firmy Pfizer.
Related resources
The advantages of donating tissue and participating in clinical trials
Adrienne Morgan explains the advantages that patients could experience when donating tissue for medical research and participating in clinical trials.
watch
Patient involvement in clinical trials
Shirley Harrison discusses her involvement with patient liaison groups and clinical trials.
watch
Clinical trials and support groups for patients
Tom Haswell of NCRI and NCRN Consumer Liaison Groups discusses his involvement in support groups and clinical trials and the importance of improving the standard of care given to patients.
watch
How can patients contribute to the improvement of cancer care?
Lt. Col. David Hamilton discusses his involvement in cancer care and the benefits of partaking in clinical trials.
watch
Should I take part in a clinical trial?
Richard Stephens of NCRI and NCRN Consumer Liaison Groups, UK discusses clinical trials and the factors patients should consider before taking part.
watch
Depression in cancer patients
Dr. Mari Lloyd-Williams discusses depression in cancer patients and the importance of complementary therapy in the treatment against it.
watch
Involving young people in cancer research will improve future therapies
Lorna Fern identifies previous issues regarding the lack of young people participating in clinical trials in order to improve future treatments.
watch
What's important for patients who have finished their cancer treatment?
Prof Maher discusses what's important for patients who have finished with there cancer treatment.
watch